Company Name: ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The company is engaged in the development/commercialization of treatments for central nervous system disorders. The company’s FDA approved NUPLAZID™ is a treatment for Parkinson’s disease psychosis.

Ticker Symbol: ACAD (NASDAQ)

Company Website: www.acadia-pharm.com

Social Media: ACADIA Pharmaceuticals LinkedIn Page    

Headquarters: San Diego, CA